Showing results (81-90 of 101) with videos related to
Sort By:
Pageof 11
Journal of Acquired Immune Deficiency Syndromes (1999)|October 26, 2023
Concurrent Testing for COVID-19 and HIV Infection at 6 High-Volume Emergency Departments in a Priority Jurisdiction for Ending the HIV Epidemic in the United StatesMoira C McNulty, Kimberly A Stanford, Dylan Eller, et al.AIDS and Behavior|April 10, 2024
Acceptability of Long-Acting Injectable Antiretroviral Therapy Among People with HIV Receiving Care at Three Ryan White Funded Clinics in the United StatesXavier A Erguera, Kimberly A Koester, Manami Diaz Tsuzuki, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 28, 2025
Policy Recommendations to Support Equitable Access to Long-Acting Injectables for Human Immunodeficiency Virus Prevention and Treatment: A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine AssociationJulia L Marcus, Andrea Weddle, Colleen F Kelley, et al.Open Forum Infectious Diseases|June 10, 2024
Patient Attitudes Toward Self- or Partner-, Friend-, or Family-Administered Long-acting Injectable Antiretroviral Therapy: A Mixed-Methods Study Across 3 Urban Human Immunodeficiency Virus ClinicsLauren F Collins, Kimberly A Koester, Moira C McNulty, et al.Open Forum Infectious Diseases|July 25, 2022
Are Patients and Their Providers Talking About Long-Acting Injectable Antiretroviral Therapy? Penetration into Clinical Encounters at Three U.S. Care SitesKaterina A Christopoulos, Jonathan Colasanti, Mallory O Johnson, et al.Journal of the American Academy of Child and Adolescent Psychiatry|August 15, 2021
Distinguishing and Managing Acute-Onset Complex Tic-like Behaviors in AdolescenceJoseph F McGuire, Shannon M Bennett, Christine A Conelea, et al.Journal of the International AIDS Society|February 13, 2026
Optimizing the patient journey: Insights from early implementation of long-acting cabotegravir and rilpivirine in four urban Ryan White-funded clinics in the United StatesXavier A Erguera, Mollie B Smith, Priyasha Pareek, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|March 13, 2025
Identifying preferred program delivery attributes for long-acting injectable cabotegravir-rilpvirine in three U.S. HIV clinics: A discrete choice experimentJose I Gutierrez, Elizabeth T Montgomery, Samantha E Dilworth, et al.Journal of the International AIDS Society|November 21, 2024
Learning from the first: a qualitative study of the psychosocial benefits and treatment burdens of long-acting cabotegravir/rilpivirine among early adopters in three U.S. clinicsKaterina A Christopoulos, Mollie B Smith, Priyasha Pareek, et al.Genome Research|March 9, 2013
Global analysis of Drosophila Cys₂-His₂ zinc finger proteins reveals a multitude of novel recognition motifs and binding determinantsMetewo Selase Enuameh, Yuna Asriyan, Adam Richards, et al.Pageof 11